How come nobody discuses new fda regulatory trial endpoints that are being allowed on ongoing cell therapy clinical trials.
No need for placebo control if it looks like obvious efficacy. Use of real world data. Its actually a game changer in the business because clinical trials will be much cheaper. Anyway one of you smart guys should elaborate on the new guidance coming forward
Cheers friends
How come nobody discuses new fda regulatory trial endpoints that...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.035(3.61%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.01 | 99.0¢ | $851.1K | 849.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 40083 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 112380 | 13 |
View Market Depth
| Last trade - 10.49am 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |